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ABSTRACT 
Approximately 40–60% of people with multiple sclerosis (MS) have memory 
problems, which adversely impact on their everyday functioning. Evidence supports 
the use of external memory aids in people with stroke and brain injury, and suggests 
they may reduce everyday memory problems in people with MS. Previous reviews of 
people with MS have only evaluated randomised trials; therefore this review included 
other methodologies. The aim was to assess the efficacy of external memory aids for 
people with MS for improving memory functioning, mood, quality of life, and coping 
strategies. Seven databases were systematically searched. Intervention studies that 
involved training in the use of external memory aids, e.g., personal digital assistants, 
with at least 75% of people with MS, were included. Based on study design, quality 
was rated with the SCED or PEDro scale. Nine studies involving 540 participants 
were included. One single case experimental design (mean of 8 on SCED scale) and 
eight group studies (mean of 5 on PEDro scale) were included. One study reported a 
significant treatment effect on subjective memory functioning, two on mood, and 
two on coping strategies. There is insufficient evidence to support or refute the 
effectiveness of external memory aids for improving memory function in people with 
MS. 
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BACKGROUND 
Multiple Sclerosis (MS) is a neurodegenerative disease characterised by wide ranging 
symptoms that may include fatigue, visual and motor physical disability, and cognitive 
impairments (Gentry, 2008). Cognitive impairments, such as dysfunction in attention, 
executive abilities and memory, are common in people with MS, with estimates varying 
from 43 to 72% (Prosiegel & Michael, 1993). Memory problems affect approximately 
40–60% of people with MS (Rao, 1995). These can be debilitating, persistent and 
frustrating both to patients and carers (Williamson, Scott, & Adams, 1996). 
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Impairments in cognitive functioning are related to low mood (Gilchrist & Creed, 
1994), and have the potential to affect independence in activities of daily living 
(Langdon & Thompson, 1996). Severe cognitive impairment presents a major barrier to 
rehabilitation, because individuals may be unable to retain advice or have difficulty 
acquiring new skills (Thomas, Thomas, Hillier, Galvin, & Baker, 2006). The safety of 
people with memory deficits can also be compromised, making them vulnerable in the 
home (e.g., forgetting to turn the oven off) and at work (e.g., forgetting deadlines). 
Impairments in memory can have a detrimental effect on the psychological well-being 
of people and others around them (Skeel & Edwards, 2001), and have significant long-
term effects on a person’s work and social life (Amato, Zipoli, & Portaccio, 2008). 
Cognitive rehabilitation is a process whereby people with neurological trauma and 
clinicians work together as a team to remediate or alleviate the resulting cognitive def-
icits (Wilson & Watson, 1996). Cognitive rehabilitation literature is divided on what strat-
egies work best for people with cognitive impairment (das Nair, Ferguson, Stark, & 
Lincoln, 2012). Restoration focuses on improving a specific cognitive function, potentially 
through regeneration, and typically involves retraining exercises. Compensation focuses 
on teaching people to adapt to the presence of a cognitive impairment, and is achieved 
through teaching people to use internal or external strategies. These include 
applying/using internal aids, such as mental imagery, mnemonics and rehearsal; or 
external memory aids, such as diaries, lists and notice boards. Technology has enabled 
the use of paging systems (Wilson, Emslie, Quirk, & Evans, 2001), mobile phones, and 
palmtop devices to reduce prospective memory problems. 
Cicerone et al. (2011) recommended the use of external compensatory devices for 
people with memory problems following traumatic brain injury (TBI) or stroke; while 
another review (de Joode, van Heugten, Verhey, & van Boxtel, 2010) found assistive tech-
nology, such as personal digital assistants (PDA), reduced prospective memory problems 
after acquired brain injury (ABI). A recent meta-analysis (Jamieson, Cullen, McGee-Lennon, 
Brewster, & Evans, 2014) including seven group studies concluded that there was strong 
evidence for the efficacy of prospective memory-prompting devices for people with ABI or 
degenerative diseases. However, Jamieson et al. (2014) only reviewed one study that 
included people with MS and concluded that there was a specific need for the investigation 
of technology for people with degenerative diseases. 
Recommendations for the provision of cognitive rehabilitation for people with MS 
have largely been based on single case experimental designs (SCED) and controlled 
clinical trials (CCT). A systematic review (O’Brien, Chiaravalloti, Goverover, & DeLuca, 
2008) concluded that there was insufficient evidence to support or refute the effective-
ness of memory rehabilitation for people with MS, due to small sample sizes, 
inadequate randomisation and blinding procedures, and impairment-level outcome 
measures. Rosti-Otajarvi and Hamalainen (2014) found that cognitive training improved 
memory span and working memory, and when combined with other neuropsychological 
methods also improved delayed memory. However, the authors concluded that the 
overall quality of included studies was relatively poor. Other Cochrane reviews, such as 
das Nair et al. (2012) and Thomas et al. (2006), also concluded that there is no evi-
dence to support or refute the effectiveness of memory rehabilitation. Furthermore, it is 
unclear which elements of memory rehabilitation are most effective, for example, 
training, mnemonics or external memory aids. das Nair et al. (2012) concluded that 
more research is required to determine whether memory rehabilitation for people with 
MS is effective in reducing memory problems. 
 An expert panel underscored the need for cognitive rehabilitation interventions 
for people with MS and recommended the use of compensatory devices (Multiple 
Sclerosis Society, 2006). There is some suggestion that external memory aids may 
be effective in reducing everyday memory problems in people with MS (das Nair & 
Lincoln, 2012). A recent Cochrane review (das Nair et al., 2012) investigated the 
evidence base for memory rehabilitation for people with MS. However, the 
majority of the literature on memory aids did not employ randomised controlled 
trial (RCT) designs, and so was not included in the Cochrane reviews. A systematic 
review of external memory aids for cognitive problems in a mixed sample 
(Gillespie, Best, & O’Neill, 2012) highlighted that most studies have been 
qualitative or single subject designs. Therefore the present systematic review 
evaluated research that employed other quantitative methodologies, such as 
quasi-experimental designs and SCEDs, in addition to RCTs. This review 
supplements Jamieson et al.’s (2014) findings by evaluating the effectiveness of 
all types of external memory aids, not just technological ones; specifically for 
people with MS; and included comprehensive cognitive rehabilitation programmes, 
provided the use of memory aids was included. 
The aim of the review was to determine whether people with MS who received 
training in the use of external memory aids showed better outcomes in their memory 
functions, mood, and quality of life, than those given other types of interventions, 
usual care, or a placebo control. 
METHODS 
Criteria for considering studies for this 
review Type of studies 
Studies evaluating the effectiveness of interventions were considered for review. There-
fore, RCTs, CCTs, before-and-after designs, and SCEDs were included. A study was 
deemed to be a RCT on the basis that the individuals followed in the trial were definitely 
or probably assigned prospectively to one of two (or more) alternative forms of healthcare 
using random allocation (Higgins & Green, 2011). SCED studies were distinguished from 
descriptive case reports by the inclusion of a control condition either through multiple 
baseline measures or a separate control measure that allowed the causal impact of the 
treatment efficacy to be inferred, as in reversal/withdrawal (ABA) designs (Tate et al., 
2008). AB (where A = baseline and B = intervention) design SCEDs were also considered. 
Studies were included with any type of control group (i.e., usual care, standard care, 
placebo, waiting list, other rehabilitation, or intervention). 
Type of participants 
Studies were limited to people with MS, regardless of clinical course or length of 
time since diagnosis. Studies with mixed diagnosis samples were included if the 
sample consisted of 75% or more MS participants, or a subgroup of MS participants 
could be identified for which separate data were available. Memory impairments 
were not defined in advance and it was assumed that people receiving training on 
the use of external memory aids had memory impairments. Studies were included if 
participants were 18 years or over, or if separate data were available for those over 
18 years. 
Types of interventions 
Interventions included in this review involved the use of, or training in the use of, 
external memory aids, defined as any external means of compensating for a 
memory deficit, e.g., diaries, PDAs, electronic calendars. Studies involving general 
cognitive rehabilitation programmes covering other aspects of cognition, such as 
executive function or visual perception, or other forms of memory rehabilitation, 
such as training on internal strategies, were included provided they explicitly pro-
vided training on the use of external memory aids. Studies were considered to 
involve an intervention if the training took place over more than a single session. 
Pharmacological interventions were not included. Where studies had active control 
groups, it was checked that these groups contained no memory content, to allow 
pure comparison with the treatment group. 
Types of outcomes 
The primary outcome was a measure that directly assessed the degree of subjective 
memory problems in everyday life. If more than one outcome measure was used to 
measure this construct, the following hierarchy was used: 
. Everyday Memory Questionnaire (EMQ; Sunderland, Harris, & Baddeley, 1984); 
Cognitive Failures Questionnaire (Broadbent, Cooper, FitzGerald, & Parkes, 1982); 
Subjective Memory Questionnaire (Davis, Cockburn, Wade, & Smith, 1995); Memory 
Functioning Questionnaire (Gilewski, Zelinski, & Schaie, 1990). This was based on 
the degree to which the measures focused on memory and their psychometric 
properties. 
Secondary outcomes were measures of objective memory, mood, quality of life, and 
coping strategies for memory problems. If more than one outcome measure was used 
to measure each construct, the following hierarchies were used: 
. Performance on memory tests such as the Wechsler Memory Scale (Wechsler, 1997 
or newer versions of this test), the Cambridge Prospective Memory Test (Wilson et 
al., 2005), the Doors and People Memory Test (Baddeley, Emslie, & Nimmo-Smith, 
1994), the Rivermead Behavioural Memory Test (RBMT; Wilson, Cockburn, & 
Badde-ley, 1985 or newer versions of this test). 
. Mood, such as the General Health Questionnaire (GHQ; Goldberg, 1992), the Hospital 
Anxiety and Depression Scale (Zigmond & Snaith, 1983), the Beck Depression Inven-
tory (BDI; Beck, Ward, Mendelson, Mock, & Erbaugh, 1961), the State-Trait Anxiety 
Inventory (Spielberger, Gorsuch, Lushene, Vagg, & Jacobs, 1983). 
. Quality of life, such as the MS Quality of Life Inventory (LaRocca et al., 1996), the MS 
Impact Scale (Hobart, Lamping, Fitzpatrick, Riazi, & Thompson, 2001), the Short 
Form–36 (SF-36; Ware & Kosinski, 2001), the Euro-QoL (Brooks, 1996). 
. Coping strategies for memory problems, such as the Adaptation to Memory Difficul-
ties Outcome Questionnaire (AMEDO; Chouliara, 2013), the Memory Aids Question-
naire (MAQ; Wilson & Moffat, 1984), the Strategy Subscale of the Multifactorial 
Memory Questionnaire (MMQ-Strategy; Troyer & Rick, 2002), the Internal and 
External Memory Aids Questionnaire (das Nair & Lincoln, 2012), the Cognitive 
Strategies Questionnaire (CSQ; Shevil & Finlayson, 2010), the PDA Checklist. 
Hierarchies were established by considering the relevance of each measure to 
each construct and their psychometric properties. MS-specific measures were placed 
above generic measures. General measures of constructs were placed above domain-
specific measures (e.g., visual, verbal, etc.). If psychometric properties were not 
available, the hierarchy was decided through discussion between authors. 
Search methods for identification of studies 
The following electronic databases were searched and all potential studies were ident-
ified by one author (RAG). 
Electronic searches 
(1) Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library, 
latest issue). 
(2) MEDLINE (1966 to August 2014). 
(3) EMBASE (1980 to August 2014). 
(4) Cumulative Index to Nursing and Allied Health Literature (CINAHL) (1982 to August 
2014). 
(5) PsycINFO (1980 to August 2014). 
(6) Web of Science (January 1981 to August 2014). 
(7) PsycBITE (2004 to August 2014). 
The search strategy used and modified for all databases can be found in Appendix A. 
Searching other resources 
Citation-tracking of primary study articles was employed and the reference lists of ident-
ified papers were searched for further relevant studies. Journals covering relevant topics 
were identified and the contents of new volumes were hand searched. Grey literature was 
accessed by searching GreyNet (http://www.greynet.org/) and Mednar (http:// 
mednar.com/). The first four pages of results on Google Scholar (http://scholar.google. 
co.uk/) were searched, with the date restricted from 2010 to present, along with web-
sites relevant to the topic area, such as the MS Society (http://mssociety.org.uk/) and the 
MS Trust (http://MSTrust.org.uk/). These websites were searched using combinations of 
the following search terms: memory (memory, cognition, remember, remembering, recall, 
plan, planning); multiple sclerosis (multiple sclerosis, MS); external aids (memory aids, 
external aids, reminder systems, assistive technology, paging). 
Data collection and 
analysis Selection of 
studies 
The review’s primary author (RAG) developed the search strategy, following consultation 
with a subject librarian and using guidance from relevant past reviews. She reviewed 
abstracts of studies identified by this strategy to identify those appearing pertinent, and 
systematically excluded studies that did not fit the inclusion criteria using the following 
hierarchy: (1) Not at least 75% participants with MS. (2) Study design did not evaluate 
the effectiveness of an intervention. (3) Intervention did not use 
external memory aids. After this initial search, duplicate papers were filtered out using 
endnote software (http://endnote.com). 
The studies that met the criteria were then subject to a full text review to select 
studies. Authors were contacted if clarification was needed in order to reach the 
decision or if it was unclear whether training on external memory aids was provided. 
Authors were also contacted to retrieve data for participants with MS in mixed 
diagnosis samples. 
Data extraction, management, and assessment of risk of bias 
The methodological quality of each of the selected studies was assessed using the 
PEDro (Maher, Sherrington, Herbert, Moseley, & Elkins, 2003) or SCED scales (Tate et 
al., 2008). The PEDro scale was used to rate the group studies and the SCED scale 
was used for SCED studies. Previous research has established that there is good inter-
rater reliability for both scales (Maher et al., 2003; Tate et al., 2008). Both are 10-
point scales, with higher scores indicating better methodological quality. For RCTs, the 
main measures of quality were whether random allocation was concealed and whether 
outcomes were conducted blind to group allocation (Maher et al., 2003). The inclusion 
of non-RCTs in this review meant that some studies did not have randomisation and 
blinding procedures, and these were considered as lower quality. 
Data for the review were extracted using a pre-prepared data extraction form that 
included items listed in Table 1. These characteristics were judged on the basis of 
information provided in the reports of the studies. Risk was assessed as being low, 
high or unclear, if the information available was insufficient to make this judgement, 
on the basis of the following criteria: random sequence generation, allocation 
concealment, blinding, incomplete outcome data. 
Broadening the inclusion criteria to non-RCT designs meant that studies without 
control groups were included for evaluation in the review. Therefore it was decided 
that performing a meta-analysis on the data would be inappropriate and inconsistent 
with the aims of the study. 
TABLE 1. Data extraction form items. 
Date, country and clinical setting of the study 
Sample size (percentage of people with MS) 
Numbers lost to follow up, at specific time points, by group 
Adequacy of matching at baseline between groups 
Inclusion and exclusion criteria 
Method of diagnosing MS and memory problem 
Description of intervention and control, including duration, frequency, intensity, setting, and individual or group 
Demographic characteristics of participants (age, gender, years since diagnosis, type of MS, years of education) 
Outcomes measured, whether primary or secondary and when they were recorded 
Random sequence generation 
Allocation concealment 
Blinding of participants and personnel 
Blinding of outcome assessment 
Intention to treat analysis used 
Incomplete data 
Other sources of bias 
Results for each outcome 
Sample size justification 
Reliability, validity and standardisation of new primary outcome measures 
Appropriate analytical techniques applied, measures of variability, probability value 
Key conclusions from authors 
RESULTS 
Description of studies 
Results of the search 
The search strategy identified 1171 results for review. Figure 1 provides a flowchart 
demonstrating the search process. 
 
  
Figure 1. Search results flowchart. 
Excluded studies 
In total 1110 studies were excluded on the basis of the exclusion criteria. During title 
and abstract screening, 1093 papers were excluded. Of these, 792 studies were 
excluded because they did not evaluate the effectiveness of an intervention, 57 
because the sample did not contain MS patients, and 244 because they did not instruct 
participants in the use of external memory aids. Fifty-two duplicates were removed, 
leaving 26 studies remaining. 
Of the 26 studies that received full text review, 17 were excluded. These excluded 
studies are summarised in Table 2. Five studies were excluded as they did not evaluate 
the effectiveness of an intervention (Beer & Kesselring, 2009; das Nair et al., 2012; 
Johnson, Bamer, Yorkston, & Amtmann, 2009; Kesselring, 2004; Rosti-Otajarvi & 
Hama-lainen, 2011), 11 studies did not instruct participants on the use of external 
memory aids (Allen, Goldstein, Heyman, & Rondinelli, 1998; Allen, Longmore, & 
Goldstein, 1995; Brissart, Leroy, & Debouverie, 2010; Brissart, Leroy, Morele, Baumann, 
& Debouv-erie, 2011; Brissart et al., 2013; Gich et al., 2011; Kardiasmenos, Clawson, 
Wilken, & Wallin, 2008; Mantynen et al., 2014; Ramio et al., 2010; Solari et al., 2004; 
Topcular et al., 2010), and one study had been presented as a work in progress at a 
conference and was not yet published and the data were not available from the author 
(Ben Ari, Hertzman, Mosberg-Galili, & Hellmann, 2012). 
Included studies 
Nine studies, including 540 participants with MS, met the inclusion criteria for this 
review (Carr, das Nair, Schwartz, & Lincoln, 2014; das Nair & Lincoln, 2012; Gentry, 
2008; Jønsson, Korfitzen, Heltberg, Ravnborg, & Byskov-Ottosen, 1993; Lincoln, Dent, 
& Harding, 2003; Lincoln et al., 2002; Shevil & Finlayson, 2010; Stuifbergen et al., 
2012; Tesar, Bandion, & Baumhackl, 2005). Please see Table 3 for details. 
Six studies were from Europe (UK, Denmark, Austria) and three from the USA. Eight 
studies were conducted in community settings and one was conducted in a rehabilita-
tion hospital. 
TABLE 2. Characteristics of excluded studies. 
Study Reason for exclusion 
Allen et al. (1995) Did not use external memory aids 
Allen et al. (1998) Did not use external memory aids 
Beer and Kesselring (2009) Did not evaluate the effectiveness of an intervention 
Ben Ari et al. (2012) Conference abstract; full article not yet published; data not available from 
author 
Brissart et al. (2010) Did not use external memory aids 
Brissart et al. (2011) Did not use external memory aids 
Brissart et al. (2013) Did not use external memory aids 
das Nair et al. (2012) Did not evaluate the effectiveness of an intervention 
Gich et al. (2011) Did not use external memory aids 
Johnson et al. (2009) Did not evaluate the effectiveness of an intervention 
Kardiasmenos et al. (2008) Did not use external memory aids 
Kesselring (2004) Did not evaluate the effectiveness of an intervention 
Mantynen et al. (2014) Did not use external memory aids 
Ramio et al. (2010) Did not use external memory aids 
Rosti-Otajarvi and Hamalainen Did not evaluate the effectiveness of an intervention 
(2011) 
Solari et al. (2004) Did not use external memory aids 
Topcular et al. (2010) Did not use external memory aids 
Carr et al. 
(2014) 
das Nair and 
Lincoln (2012) 
Single blind RCT, 
randomisation by 
independent researcher, 
computer generated random 
number sequence 
Single blind RCT, 
randomisation by off-site 
independent randomisation 
centre, computer generated 
random number sequence 
n = 48 with MS 
Randomised (A:24 B:24) 
Intention to treat analysis 
used 
Mean age: 54.3 years 
Education: 14.6 years 
Groups comparable on all 
variables 
n = 39 with MS 
Randomised (A:12 B:17 
C:10) 
Intention to treat analysis 
used 
Mean age: 47.2 years 
Education: 14.1 years 
Groups comparable on all 
variables  
Gentry (2008) Before-and-after group design n = 21 
Intention to treat analysis 
not used 
Median age: 50 years 
Median time since 
diagnosis: 14 years 
TABLE 3. Characteristics of included studies. 
Study Methods Participants Interventions Outcomes Notes 
Significant difference between Analysis used in this 
groups on GHQ-28 at 8 months. review: A vs. B 
Non-significant differences 
between groups on EMQ or MS-
Impact Scale at 4 or 8 months, or 
GHQ-28 at 4 months. 
Non-significant differences across Analysis used in this 
compensation and control group review: A vs. C 
post-treatment, on EMQ, RBMT-E, 
GHQ or Internal and External 
Memory Aids Questionnaire. 
Non-significant change over time None 
on the RBMT-E 
(Continued) 
Groups: 
A: Group memory rehabilitation, 10 x 1.5 
hour sessions. Combination of restitution 
and compensation strategies. 
B: Waiting list control 
Groups: 
A: Compensation—how to use external 
memory aids and taught about internal 
memory aids 
B: Restitution—taught about internal 
memory aids, exercises on encoding and 
retrieval strategies, attention retraining 
C: Attention placebo—self-help group, 
relaxation techniques 
10 sessions, 90 minutes 
A: Pretraining, usual care (8 weeks) 
B: Individual format intervention 
training: PDA installation and 
demonstration of calendar and alarm 
usage; enter feature tasks. 3 weeks, 4 
visits: 2 × 90 minutes, 2 × 60 minutes 
C: Post-training, can contact administrator 
for questions (8 weeks) 
TABLE 3. Continued. 
Study Methods Participants Interventions Outcomes Notes 
None Closed envelope 
randomisation (RCT) 
(Continued) 
Jønsson et al. 
(1993) 
Lincoln et al. 
(2002) 
Lincoln et al. 
(2003) 
Single blind RCT; 
independent phone 
randomisation Computer-
generated numbers 
Single case experimental 
design: AB design 
n = 40 with MS (E:20; 
C:20) hospital in-pts (16 + 
16 completed) 
Intention to treat analysis 
not used 
Mean age: 44.5 years (SD: 
8.3) 
Education: 11.5 years (SD: 
2.5) 
Gender: 19F, 21M 
Groups comparable on all 
variables, except visuo-
spatial memory and visual 
perception (E group more 
impaired) 
n = 240 
Randomised (A:82; B:79; 
C:79) 
Completed (A:77; B:71; 
C:73) 
Intention-to-treat analysis 
used 
Mean age: 43 years 
Age left education: 16 
years 
Groups comparable on 
all baseline variables n 
= 29 
Mean age: 43 years 
Age left education: 16 
years 
Individual goal-directed treatment 
E: Compensation (internal and external 
memory aids), substitution, direct training 
and neuropsychotherapy 
C: Attention placebo—discussion and 
games 
1–1.5 hours 3 times a week; mean 17.2 
hours 
Individual treatment 
A: Only baseline assessment with no 
feedback 
B: Detailed cognitive assessment with 
feedback 
C: Detailed cognitive assessment with 
feedback and training on internal and 
external memory aids 
Individual treatment 
A: Baseline 
B: Detailed cognitive assessment with 
feedback and training on internal and 
external memory aids 
Short-term effects: E significantly 
effected performance on BDI 
Long-term effects: E had a 
significant effect on visuo-spatial 
and memory; C had significant 
effect on BDI (more depressed at 
second follow-up) 
No significant differences between 
groups on EMQ, GHQ, SF-36 or 
MAQ at follow-up 1 or 2 for patient 
or relative data 
Significant reduction in frequency 
of memory problems per week 
from baseline to intervention on 
diaries 
Analysis used in 
this review: A vs. C 
Diaries were 
completed daily, 
reporting any 
cognitive difficulties 
that interfered with 
daily life 
 
N o n e  
N o n e  
N o n e  
TABLE 3. Continued. 
Study Methods Participants Interventions Outcomes Notes 
Shevil and Before-and after-group design n = 41 Group format Significant change over time on 
Finlayson Intention-to-treat analysis Problem solving techniques, taught CSQ in effectiveness of strategies 
(2010) not used internal and external strategies and used, no significant effect in 
Mean age: 52.4 years application. number of strategies used. Effect 
Time since diagnosis 13 5 session, (2 hours, weekly) size small 
years 
Stuifbergen Single blind RCT; random n = 63 Group format Significant interaction effect of 
et al. (2012) number sequence and sealed Randomised (E:36; C:27) 8 sessions (2-hour sessions once a week) group and time between baseline 
envelope Completed (E:33; C:25) E: Training on use of compensatory and follow-up on MMQ-Strategy  
Intention-to-treat analysis strategies including external memory aids; 
used computer assisted cognitive training  
Age: 51–60 years (44% of programme (home-based practice 45 sample); 36–50 years 
(43% minutes 3 times a week) 
of sample); 20–35 years C: Wait list control 
(13% sample) 
Groups comparable on all 
baseline variables except 
DKEFS (C group scored 
higher) 
Tesar et al. Simple random sampling with n = 19 (E:10; C:9) Group treatment No significant group x time effects 
(2005) independent allocation Mean age: 46 years E: 12 x 1-hour session in 4 weeks on BDI, VLT or NVLT 
Intention-to-treat analysis Neuropsychological training programme; 
not used computer-based direct functional training 
Groups comparable on on compensatory strategies: internal and 
baseline variables external memory supports. 
C: Rehabilitation only (OT, PT, ST etc.) 
Tests used: EMQ: Everyday Memory Questionnaire; GHQ: General Health Questionnaire; RMBT-E: Rivermead Behavioural Memory Test–Extended; BDI: Beck Depression Inventory; 
SF-36: Short Form; MAQ: Memory Aids Questionnaire; CSQ: Cognitive Strategies Questionnaire; DKEFS: Delis-Kaplan Executive Function System; MMQ-Strategy: Strategy Subscale 
of the Multi-factorial Memory Questionnaire; VLT: Verbal Learning Test; NVLT: Non-verbal Learning Test. 
Other abbreviations: E: Experimental; C: Control. 
Types of design. Six studies were RCTs (Carr et al., 2014; das Nair & Lincoln, 2012; 
Jønsson et al., 1993; Lincoln et al., 2002; Stuifbergen et al., 2012; Tesar et al., 2005). 
Two studies employed before-and-after group designs (Gentry, 2008; Shevil & Finlay-
son, 2010), and one study was a SCED (Lincoln et al., 2003). Within the RCTs, the 
method of generating the randomisation schedule was mentioned in all but one study 
(Tesar et al., 2005). Independent randomisation was reported in three studies (Carr et 
al., 2014; das Nair & Lincoln, 2012; Lincoln et al., 2002) and two studies used a closed 
envelope system (Jønsson et al., 1993; Stuifbergen et al., 2012). Outcomes were 
assessed by an individual blind to group allocation in five RCTs, but not in Tesar et al. 
(2005). The SCED (Lincoln et al., 2003) employed an AB design for 29 participants 
within the treatment group of the RCT (Lincoln et al., 2002). 
Types of participants. The diagnosis of participants was based on the Poser criteria 
(Poser et al., 1983) in four studies (das Nair & Lincoln, 2012; Lincoln et al., 2002, 2003; 
Tesar et al., 2005); the Jønsson et al. (1993) study used the Schumacher criteria (Schu-
macher et al., 1965), and four studies relied on self-reported diagnoses (Carr et al., 
2014; Gentry, 2008; Shevil & Finlayson, 2010; Stuifbergen et al., 2012). Seven studies 
had mixed types of MS—relapsing remitting MS (RRMS), primary progressive MS 
(PPMS) and secondary progressive MS (SPMS) (Carr et al., 2014; Gentry, 2008; Lincoln 
et al., 2002, 2003; Jønsson et al., 1993), or RRMS and SPMS (das Nair & Lincoln, 2012; 
Tesar et al., 2005). The subtypes of MS were not described by Shevil and Finlayson 
(2010) or Stuifbergen et al. (2012). The sample size in the studies varied from 19 (Tesar 
et al., 2005) to 240 (Lincoln et al., 2002); the number of participants receiving active 
treatment similarly varied from 10 (Tesar et al., 2005) to 82 (Lincoln et al., 2002). The 
majority of participants were in their mid to late 40s, with mean ages ranging from 42.1 
years (Lincoln et al., 2002) to 54.3 years (Carr et al., 2014). Eight studies reported there 
to be a higher percentage of women than men in their samples, with the percentage of 
women ranging from 88% (Stuifbergen et al., 2012) to 47% (Jønsson et al., 1993). 
Time since diagnosis ranged from a mean of 9 years (Tesar et al., 2005) to 15 years 
(Jønsson et al., 1993); and years of education varied from a mean of 11.5 years 
(Jønsson et al., 1993) to the majority having a BSc or postgraduate education 
(Stuifbergen et al., 2012). In the six studies comparing performance between groups, 
four studies had groups comparable at baseline on all variables (Carr et al., 2014; das 
Nair & Lincoln, 2012; Lincoln et al., 2002; Tesar et al., 2005); the remaining two studies 
were comparable on all baseline variables except visuo-spatial and visual perception 
(Jønsson et al., 1993) and executive function (Stuifbergen et al., 2012). 
Types of interventions. Four studies employed individual treatment (Gentry, 2008; 
Jønsson et al., 1993; Lincoln et al., 2002, 2003) and five studies used group interventions 
(Carr et al., 2014; das Nair & Lincoln, 2012; Shevil & Finlayson, 2010; Stuifbergen et al., 
2012; Tesar et al., 2005). Two studies ran three-group comparisons (das Nair & Lincoln, 
2012; Lincoln et al., 2002) and three studies employed two-group comparisons (treatment 
vs. control) (Carr et al., 2014; Stuifbergen et al., 2012; Tesar et al., 2005). Two studies 
evaluated the performance of a single group (Gentry, 2008; Shevil & Finlayson, 2010). 
Gentry (2008) compared performance before treatment and immediately after treatment. 
Shevil and Finlayson (2010) compared performance before treatment, after a post-training 
period, and at follow-up. One study evaluated performance at multiple 
time points at baseline and at multiple time points during intervention (Lincoln et al., 
2003). Most programmes were 3 weeks (Gentry, 2008) to 10 weeks (Carr et al., 2014; 
das Nair & Lincoln, 2012) long. Two individual treatment studies specified that the time 
period was a maximum of 6 months post-assessment (Lincoln et al., 2002, 2003). 
Sessions were between one hour (Tesar et al., 2005) and two hours (Shevil & Finlayson, 
2010; Stuifbergen et al., 2012), and participants met one to three times a week in all 
studies, except two where it depended on the needs of the participant (Lincoln et al., 
2002, 2003). Eight studies employed comprehensive cognitive or memory rehabilitation 
programmes, which all included teaching participants how to use external memory aids, 
as well as internal memory strategies. Of these eight studies, five (Carr et al., 2014; das 
Nair & Lincoln, 2012; Jønsson et al., 1993; Stuifbergen et al., 2012; Tesar et al., 2005) 
ran programmes that also included cognitive training, such as computerised functional 
training and attention retraining. One study also included a “neuropsychotherapy” 
component (Jønsson et al., 1993), and one study provided psycho-education (Shevil & 
Finlayson, 2010). Six studies (Jønsson et al., 1993; Lincoln et al., 2002, 2003; Shevil & 
Finlayson, 2010; Stuifbergen et al., 2012; Tesar et al., 2005) were cognitive rehabilitation 
programmes, which were not specific to memory rehabilitation, therefore the amount of 
time dedicated to memory rehabilitation, let alone external memory aids, is unknown. 
Gentry (2008) was the only study with the content solely restricted to teaching partici-
pants how to use external memory aids. This study involved the installation of PDA soft-
ware and demonstration of how to use calendar and alarm functions on a PDA, followed 
by a post-training period where administrative support was available if needed. 
Risk of bias in included studies 
The risk of bias in the nine included studies was mixed, with high risk of detection bias 
associated with the lack of blinding in one group study (Tesar et al., 2005), and two group 
studies at high risk of selection, detection and performance bias associated with the lack 
of a control group, and therefore absence of randomisation, allocation and blinding 
procedures (Gentry, 2008; Shevil & Finlayson, 2010). The risk of bias in the SCED (Lincoln 
et al., 2003) was considered to be generally low, but with some risk of observer bias and 
bias in determining the treatment efficacy due to the AB design. The risk of bias was 
deemed to be unclear in five studies, due to lack of information when reporting the 
methods used for random sequence generation (Jønsson et al., 1993; Stuifbergen et al., 
2012; Tesar et al., 2005), blinding (Jønsson et al., 1993), and how incomplete data were 
handled (Gentry, 2008; Shevil & Finlayson, 2010; Tesar et al., 2005). 
The methodological quality of group studies using the PEDro scale (Maher et al., 2003) 
are summarised in Table 4, and single case experimental designs using the SCED scale 
(Tate et al., 2008) in Table 5. Group studies received a mean score of 5 (SD = 2.51; 
range = 2–8) out of a possible 10. The SCED scored 8 out of a possible 10. 
Random sequence generation in group studies. Three group studies were 
judged to have a low risk of selection bias on the basis of having adequate random 
sequence generation, using a computerised random number generator by an independent 
agency or researcher (Carr et al., 2014; das Nair & Lincoln, 2012; Lincoln et al., 2002). 
Three studies were unclear in their explanation of random sequence generation, and thus 
the risk of bias was unclear (Jønsson et al., 1993; Stuifbergen et al., 2012; Tesar et al., 
2005). Two studies had no control group and therefore there was a high risk of selection 
bias (Gentry, 2008; Shevil & Finlayson, 2010). 
TABLE 4. Risk of bias table for group studies, using the PEDro scale (Maher et al., 2003). 
d a s  
Carr Nair Jønsson Lincoln Shevil and Tesar 
Criteria met on et al. et al. Gentry et al. et al. Finlayson Stuifbergen et al. 
PEDro scale (2014) (2012) (2008) (1993) (2002) (2010) et al. (2012) (2005) 
 
Subjects were 
randomly 
allocated into 
groups 
Allocation was 
concealed 
Groups matched 
at baseline 
V V N N V N V N 
V V N V V N V V 
V V N V V N V V 
Blinding of all N N N N N N N N 
subjects 
B l i n d i n g  o f  a l l  N  N  N  N  N
 N  N  N   
t h e r a p i s t s  w h o  a d m i n i s t e r e d  
t h e r a p y  
Blinding of all V V N N V N V N  
assessors 
K e y  o u t c o m e  N  V  V  N  V  V
 V  N   
o b t a i n e d  f r o m  m o r e  t h a n  8 5 %  
s u b j e c t s  
Subjects V V N N N N N N 
received 
intended 
condition or 
intention to treat 
used 
Between-group V V N V V N V V  
statistical 
comparisons 
reported 
Point measures V V V N V V V V  
and measures for 
variability 
provided 
TOTAL 7 8 2 3 7 2 7 4 
Allocation in group studies. Six group studies were judged as having a low risk of 
selection bias on the basis of adequate group allocation concealment using a computerised 
random number generator by an independent unit (Carr et al., 2014; das Nair & Lincoln, 
TABLE 5. Risk of bias table for single participant designs on the SCED scale (Tate et al., 2008). 
Criteria met on the SCED scale Lincoln et al. (2003) 
Target behaviours—precise and repeatable measures V 
3 phases, study is ABA or multiple baseline N 
Baseline (pre-treatment). Sufficient sampling V 
Treatment phase. Sufficient sampling V 
Raw data points recorded V 
Inter-rater reliability was established for at least one measure N 
Independence of assessors V 
Statistical analysis V 
Replication either across subjects, therapists or settings V 
Evidence for generalisation V 
TOTAL 8 
2012; Lincoln et al., 2002), or having a separate member of staff, not involved with the 
study to complete allocation (Tesar et al., 2005), or using a closed envelope system 
(Jønsson et al., 1993; Stuifbergen et al., 2012). Two studies had no control group and 
therefore there was a high risk of selection bias (Gentry, 2008; Shevil & Finlayson, 2010). 
Blinding in group studies. Four group studies were single blind (Carr et al., 2014; 
das Nair & Lincoln, 2012; Lincoln et al., 2002; Stuifbergen et al., 2012), with a blinded 
outcome assessor, indicating a low risk of detection bias. Three studies had a high risk 
of bias (Gentry, 2008; Shevil & Finlayson, 2010; Tesar et al., 2005) as they had no 
blinding procedures, and Jønsson et al. (1993) provided an unclear description of the 
blinding procedures employed. 
Incomplete outcome data in group studies. Four group studies addressed 
incomplete data, indicating a low risk of attrition bias. In one study (das Nair & Lincoln, 
2012), list-wise deletion was utilised and baseline data were imputed for missing follow-up 
data. In another study (Lincoln et al., 2002), analysis covered just those who completed 
outcomes, however it also included those who did not receive the intervention as planned 
in an intention-to-treat analysis. One study (Stuifbergen et al., 2012) replaced missing 
values with the last observation value carried forward if the participant did not complete 
later measurements, or imputed if an intermediate value was missing. In another study 
(Carr et al., 2014), if missed items occurred for less than 10% of questions in a 
questionnaire, the missing item was replaced with the mean for the questionnaire. The 
four remaining studies did not address incomplete data: two studies did not use intention-
to-treat analysis after reporting dropouts (Gentry, 2008; Shevil & Finlayson, 2010) and 
two studies provided no explanation of how dropout data were dealt with (Jønsson et al., 
1993; Tesar et al., 2005), thus the risk of bias was unclear. 
Risk of bias in SCED studies. The risk of bias in the one SCED study was generally 
low (Lincoln et al., 2003). The measure of target behaviours was specified and the 
variability in behaviour was established through sufficient sampling during the baseline 
and treatment phase. Verification of treatment efficacy was demonstrated using statistical 
analysis and generalisation was assured through replication across subjects and transfer 
to beyond target behaviours. However, there was a high risk of bias in determining treat-
ment efficacy since an AB design was used. There was also a high risk of observer bias, 
as inter-rater reliability was not established for measures. 
Effects of interventions 
Parametric and nonparametric statistical analyses were used to compare groups. 
Significance testing was reported in all studies, however the appropriate measures of 
variability were not. 
Outcome 1: Subjective memory measures 
Four studies (Carr et al., 2014; das Nair & Lincoln, 2012; Lincoln et al., 2002, 2003) 
used subjective measures of participants’ memory functioning. Three studies (Carr et 
al., 2014; das Nair & Lincoln, 2012; Lincoln et al., 2002) used the EMQ (Sunderland et 
al., 1984), and one study (Lincoln et al., 2003) used diaries to record specific instances 
of memory difficulties that interfered with daily life. One study (Lincoln et al., 2003) 
found a significant effect of treatment on subjective memory functioning, demon-
strated by a significant reduction (p < .01) in the frequency of reported memory pro-
blems per week from baseline to intervention. Subgroup analysis of MS participants 
from das Nair and Lincoln (2012) detected no significant effect of treatment; Carr et 
al. (2014) and Lincoln et al. (2002) found no significant treatment effect. 
Outcome 2: Objective memory measures 
Two studies (das Nair & Lincoln, 2012; Gentry, 2008) included objective measures of 
memory; both used the RBMT-E (Wilson et al., 1985). Subgroup analysis of MS partici-
pants from das Nair and Lincoln (2012) showed no significant effect of treatment; 
Gentry (2008) also found no significant long-term effect. 
Outcome 3: Mood 
Five studies (Carr et al., 2014; das Nair & Lincoln, 2012; Jønsson et al., 1993; Lincoln et 
al., 2002; Tesar et al., 2005) included measures of participants’ mood. All measured 
mood both immediately after treatment and at long-term follow-up. Three of these 
studies (Carr et al., 2014; das Nair & Lincoln, 2012; Lincoln et al., 2002) used the GHQ 
(Goldberg, 1992) and two (Jønsson et al., 1993; Tesar et al., 2005) used the BDI (Beck et 
al., 1961). A significant effect of intervention was found at long-term follow-up in one 
study (Carr et al., 2014). Jønsson et al. (1993) found a significant effect of treatment on 
mood, however it was due to the control group worsening in mood over time. 
Outcome 4: Quality of life 
Two studies included a measure of quality of life (Carr et al., 2014; Lincoln et al., 
2002). Carr et al. (2014) used the MS Impact Scale (Hobart et al., 2001), and Lincoln 
et al. (2002) used the SF-36 (Ware & Kosinski, 2001). No effect of treatment on 
quality of life was found either immediately or at long-term follow-up. 
Outcome 5: Coping strategies for memory problems 
Four studies (das Nair & Lincoln, 2012; Lincoln et al., 2002; Shevil & Finlayson, 2010; 
Stuif-bergen et al., 2012) used measures of coping strategies for memory problems. One 
study (Shevil & Finlayson, 2010) found a significant treatment effect (p < .05) on the 
effectiveness of strategies used on the CSQ (Shevil & Finlayson, 2010), but no significant 
effect on the number of strategies used. One study (Stuifbergen et al., 2012) detected a 
significant treatment effect (p < .01) on the use of compensatory strategies on the MMQ-
Strategy (Troyer & Rick, 2002). No significant treatment effect on coping strategies was 
reported in two studies (das Nair & Lincoln, 2012; Lincoln et al., 2002) on the Internal and 
External Memory Aids Questionnaire (das Nair & Lincoln, 2012) and the MAQ (Lincoln et 
al., 2002; Wilson & Moffat, 1984). 
DISCUSSION 
Summary of main results 
Despite evidence demonstrating the existence of memory problems in people with MS 
and the associated everyday problems, literature examining the effectiveness of exter-
nal memory aids on alleviating memory problems in people with MS remains weak. This 
review included a variety of study designs, in an attempt to collate all available 
evidence. However, few additional studies were identified that were not included in 
previous reviews confined to RCTs. 
Nine studies were included in this review: six were RCTs, two employed before-and-after 
group designs, and one was a SCED. One study specifically evaluated an external memory 
aid; the others were either memory rehabilitation or cognitive rehabilitation studies that 
included a component attending to external memory aids. These studies were published 
between 1993 and 2014 and the majority were of poor quality; lacking detailed description 
of the randomisation procedures, blinding, and dealing with incomplete outcome data. 
Although the one SCED (Lincoln et al., 2003) scored 8 out of 10 for methodological quality, 
the mean for group studies was only 5 out of 10. Only five of the included studies evaluated 
participant outcomes using ecologically valid memory measures (Carr et al., 2014; das Nair 
& Lincoln, 2012; Gentry, 2008; Lincoln et al., 2002, 2003); five studies included measures of 
participants’ mood, and only two assessed quality of life. 
The evidence for the effectiveness of teaching people with MS to use external 
memory aids to improve everyday memory functioning was limited, with only one study 
reporting an improvement on a subjective memory measure (Lincoln et al., 2003), and 
none demonstrating benefits on objective measures of memory. However, it should be 
noted that only four studies employed subjective memory measures, and only two used 
objective memory measures. Five studies assessed participants’ mood, although only 
two studies reported positive results following intervention (Carr et al., 2014; Jønsson 
et al., 1993), and no studies reported an effect on quality of life. Five studies assessed 
the use of coping strategies for memory problems, with two reporting beneficial effects 
of treatment (Shevil & Finlayson, 2010; Stuifbergen et al., 2012). 
There are several limitations of this review that need to be considered. Despite sys-
tematically searching seven electronic databases it is possible that not all relevant studies 
were identified. Studies, particularly SCEDs, may have been published in journals that 
were not covered by the databases, or may not have been identified with the search 
strategy used. Due to the nature of memory problems affecting many areas of life, it is 
possible that some relevant articles did not use the words applied in the search strategy. 
For example, if an article was named “problems at work”, it would not have been 
included. Selection was also performed by only one author, which reduces the likelihood 
that errors are detected, compared with employing a review team. Another issue that 
should be considered is the change in the way SCEDs are classified. This review classifies 
SCEDs using the SCED scale (Tate et al., 2008), which includes AB designs, such as the 
Lincoln et al. (2003) study. A revised classification system has since been developed, the 
RoBiNT Scale (Tate et al., 2013), which states that AB designs should not be classified as 
SCEDs due to the inability to determine cause and effect, with the absence of ABA 
reversal or multiple baseline designs. Therefore it should be noted that the included SCED 
(Lincoln et al., 2003) does not provide staggered baselines. 
This review evaluated the evidence for the use of external memory aids for people 
with MS, however only one study provided data on participants who had solely received 
dedicated training in the use of external memory aids. The majority of studies involved 
comprehensive cognitive rehabilitation programmes, and thus were aimed at tackling a 
range of cognitive deficits. Therefore, it is difficult to deduce how much time was spent 
on memory rehabilitation in general, let alone external memory aids specifically. Conse-
quently, the results of this review suggested that there was no evidence to support or 
refute the effectiveness of external memory aids on subjective or objective reports of 
memory function. 
Quality of the evidence 
Evidence for the effectiveness of external memory aids for people with MS is poor. Only 
six RCTs were identified, of these, five were single blind, although it should be noted that 
the Jønsson et al. (1993) paper stated that blinding was problematic as patients could 
easily unmask their allocation in conversation. Eight of the nine studies were published 
after the publication of the CONSORT statement (Moher, Schultz, & Altman, 2003), 
however these guidelines were not followed in the majority of included studies. The 
randomisation protocol was unclear in three studies (Jønsson et al., 1993; Stuifbergen et 
al., 2012; Tesar et al., 2005). All RCTs appeared to have adequate allocation conceal-
ment. Inclusion and exclusion criteria were generally defined well and all described the 
flow of participants through the study. The description of interventions and control con-
ditions were inadequate in the majority of studies, and the choice of outcome measures 
used was extremely poor, with only four studies employing ecologically valid memory 
measures. Feedback from participants was only obtained in two studies (das Nair & 
Lincoln, 2012; Tesar et al., 2005); responses to this questionnaire were positive. 
Agreement and disagreement with other studies or reviews 
This review adds to the recent Cochrane review on memory rehabilitation for people 
with MS (das Nair et al., 2012) by including five extra studies: two studies published 
since the review and three non-RCT designs. This review also evaluated only the treat-
ment compared to control conditions in two previously included studies (das Nair & 
Lincoln, 2012; Lincoln et al., 2002). When conducting this review there was the 
assumption that broadening the criteria to include non-RCTs would yield results that 
had been excluded from previous Cochrane reviews. However, only two CCTs and one 
SCED were identified. Our findings complement the das Nair et al. (2012) and Rosti-
Otajarvi and Hamalainen (2014) Cochrane reviews, which both concluded that there 
was no evidence to suggest that memory rehabilitation was more effective than a 
control. This review supports the opinion from both previous reviews that studies 
evaluating the effectiveness of memory rehabilitation are of poor quality. This review 
also complements the findings of the Thomas et al. (2006) Cochrane review on 
psychological interventions for MS, showing that interventions designed to help people 
with cognitive impairments were inconclusive. Although this review does not support 
the conclusions of recent reviews of neuropsychological rehabilitation (Cicerone et al., 
2011; de Joode et al., 2010) in their recommendations of the use of compensatory 
aids for people experiencing memory problems, it does support a recent review 
(Jamieson et al., 2014) that concluded there is still a specific need for investigations of 
technology for people with degenerative diseases. 
CONCLUSIONS 
This review found no evidence to support or refute that external memory aids improved 
everyday memory function, mood or quality of life for people with MS. Therefore, clin-
icians are encouraged to use SCED methodology to evaluate the effectiveness of any 
interventions they are providing in clinical practice for memory problems in people with 
MS. 
It is also suggested that more RCTs are necessary to provide conclusive evidence as 
to whether or not external memory aids are effective at reducing memory problems for 
people with MS. 
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Appendix 
Search strategy 
(1) Multiple sclerosis (exp) 
(2) (Demyelinating and autoimmune and disease) or (demyelination) or (demyelinat-ing 
and diseases) or (optic and neuritis) or (Myelitis and transverse) or (Neuromye-litis 
and optica) or (Disseminated and sclerosis) or (Devics and disease) 
(3) 1 or 2 
(4) Memory disorder (exp) 
(5) Memory (exp) 
(6) Attention or Cognit* or (Cognit* and (disorders or impair*)) or Concentrat* or Dis-
tract* or Alert* or Amne?sia or (Planning and problem*) or Confabulat* or Recall or 
(Coniti* and retention) or Recogni* or (Prospective and memory) or Forget* or 
(Executive and function*) or (Executive and behavio?r) or dysexecutive or planning 
(7) 4 or 5 or 6 
(8) (Assistive and technolog*) or (Assistive and technolog* and device) or (Adaptive 
and technolog*) or (Assistive and device*) or pager* or (paging and system*) or 
(Technolog* and aid*) or (pocket and (pc or computer)) or (palm and top) or (per-
sonal and digital and assistant) or PDA or (self and help and device*) or (computer* 
and handheld) 
(9) (Memory and aid*) or (Memory and strateg*) or Compensat* or (Electronic and 
aid*) or (External and aid*) or (External and compensat*) or (memory and 
device*) or (remind* and system) or remind* or (cogniti* and prosthetic*) or 
substitute* 
(10) 8 or 9 
(11) Rehabilitation (exp) 
(12) Neurorehab* or Therap* or Treatment or Intervention or Strateg* or Management 
or (Cogniti* and rehab*) or (Therap* and computer and assist*) 
(13) 11 or 12 
(14) 3 and 7 and 10 and 13 
